Products
Online Inquiry
Our Products Cannot Be Used As Medicines Directly For Personal Use.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
Semagacestat (LY450139)
Cat No.
CEI-0208
Description
Semagacestat (LY450139) can inhibit gamma-secretase such as, Abeta42, Abeta40 and Abeta38, with IC50 of 10.9 nM, 12.1 nM and 12.0 nM.
CAS No.
425386-60-3
Molecular Weight
361.44
Purity
>99%
Storage
2 years at -20 centigrade
Targets
Abeta42, Abeta40, Abeta38
Molecular Formula
C19H27N3O4
Chemical Name
(S)-2-hydroxy-3-methyl-N-((S)-1-((S)-3-methyl-2-oxo-2,3,4,5-tetrahydro-1H-benzo[d]azepin-1-ylamino)-1-oxopropan-2-yl)butanamide
Solubility
DSMO 72 mg/mL Water
In vitro
Semagacestat (LY450139) is a novel, smallmolecular weight inhibitor of gamma-secretase inhibitor. This inhibitor is developed for treating Alzheimers disease (AD), which is a progressive neurodegenerative disease.
In vivo
Oral administration of Semagacestat (1 mg/kg) to 5.5-month old APP-transgenic Tg2576 mice significantly ameliorates memory deficits on spatial working memory using the Y-maze task, which disappears after 8 days subchronic dosing.
Download
Download Datasheet